Hubei NewLand

Hubei Newland Pharmaceutical is a China-based pharmaceutical company that focuses on the development, manufacturing, and global distribution of active pharmaceutical ingredients (APIs) and finished dosage forms. Established in 2006 and headquartered in Xianning, the company has built a strong reputation for producing high-quality small molecule drugs, particularly in the areas of neurology, cardiovascular health, and anti-virals. Its core product line includes widely used medications such as Gabapentin, Pregabalin, and various angiotensin II receptor blockers. Hubei Newland operates state-of-the-art manufacturing facilities that adhere to international GMP standards, enabling it to serve as a reliable partner for both domestic and international pharmaceutical markets. The company also provides contract manufacturing and custom synthesis services to support the broader life sciences industry.